Protab Ltd.
JERUSALEM, IL· latest recorded location
Protab Ltd. is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 4
- Granted in 2026 so far
- 0
- Most recent grant
- 25 Mar 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
By publication year.
Technology areas
Share of 6 documents
Recent patents
- Humanized antibodies specific for HSP65-derived peptide-6 methods and uses thereof25 Mar 2014US 8,680,241 B2
- Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation4 Feb 2014US 8,642,041 B2
- Humanized antibodies specific for hsp65-derived peptide-6, methods and uses thereof3 Aug 2017US 2017/0218056 A1
- Humanized antibodies specific for hsp65-derived peptide-6, methods and uses thereof19 Jun 2014US 2014/0170138 A1
- Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof21 Jun 2012US 2012/0156201 A1
- Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation19 Jan 2012US 2012/0014973 A1
Most cited
By later US patents